Advertisement

AJC Editor's Consensus: Rheumatoid Arthritis and Atherosclerotic Cardiovascular Disease

      This continuing medical education activity is supported by an educational grant from Amgen, Thousand Oaks, California.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Libby P.
        • Ridker P.M.
        • Maseri A.
        Inflammation and atherosclerosis.
        Circulation. 2002; 105: 1135-1143
        • Kimball A.B.
        • Robinson Jr, D.
        • Wu Y.
        • Guzzo C.
        • Yeilding N.
        • Paramore C.
        • Fraeman K.
        • Bala M.
        Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.
        Dermatology. 2008; 217: 27-37
        • Friedewald V.E.
        • Kornman K.S.
        • Beck J.D.
        • Genco R.
        • Goldfine A.
        • Libby P.
        • Offenbacher S.
        • Ridker P.M.
        • Van Dyke T.E.
        • Roberts W.C.
        The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease.
        Am J Cardiol. 2009; 104: 59-68
        • Savoia C.
        • Schiffrin E.L.
        Inflammation in hypertension.
        Curr Opin Nephrol Hypertens. 2006; 15: 152-158
        • Pradhan A.D.
        • Manson J.E.
        • Rifai N.
        • Buring J.E.
        • Ridker P.M.
        C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
        JAMA. 2001; 286: 327-334
        • Pasceri V.
        • Yeh E.T.H.
        A tale of two diseases: atherosclerosis and rheumatoid arthritis.
        Circulation. 1999; 100: 2124-2126
        • Libby P.
        Role of inflammation in atherosclerosis associated with rheumatoid arthritis.
        Am J Med. 2008; 121: S21-S31
        • Ridker P.M.
        • Danielson E.
        • Fonseca F.A.H.
        • Genest J.
        • Gotto Jr, A.M.
        • Kastelein J.J.P.
        • Koenig W.
        • Libby P.
        • Lorenzatti A.J.
        • MacFadyen J.G.
        • Nordestgaard B.G.
        • Shepherd J.
        • Willerson J.T.
        • Glynn R.J.
        • JUPITER Study Group
        Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
        N Engl J Med. 2008; 359: 2195-2207
        • Ridker P.M.
        • Friedewald V.E.
        • Davidson M.H.
        • Willerson J.T.
        • Roberts W.C.
        The editor's roundtable: the JUPITER trial—initial results and clinical implications.
        Am J Cardiol. 2009; 103: 1417-1425
        • Silman A.J.
        • Hochberg M.C.
        Epidemiology of the Rheumatic Diseases.
        2nd ed. Oxford University Press, Oxford, United Kingdom2001
        • Gabriel S.E.
        Why do people with rheumatoid arthritis still die prematurely?.
        Ann Rheum Dis. 2008; 67: iii30-iii34
        • Gregersen P.K.
        • Silver J.
        • Winchester R.J.
        The shared epitope hypothesis.
        Arthritis Rheum. 1987; 30: 1205-1213
        • van der Heijde D.M.
        • van 't Hof M.
        • van Riel P.L.
        • van de Putte L.B.
        Development of a disease activity score based on judgment in clinical practice by rheumatologists.
        J Rheumatol. 1993; 20: 579-581
        • Prevoo M.L.
        • van 't Hof M.A.
        • Kuper H.H.
        • van Leeuwen M.A.
        • van de Putte L.B.
        • van Riel P.L.
        Modified disease activity scores that include twenty-eight-joint counts.
        Arthritis Rheum. 1995; 38: 44-48
        • Grigor C.
        • Capell H.
        • Stirling A.
        • et al.
        Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised control study.
        Lancet. 2004; 364: 263-269
        • Rantapaa-Dahlqvist S.
        What happens before the onset of rheumatoid arthritis?.
        Curr Opin Rheumatol. 2009; 21: 272-278
        • Gabriel S.E.
        Cardiovascular morbidity and mortality in rheumatoid arthritis.
        Am J Med. 2008; 121: S9-S14
        • Maradit-Kremers H.
        • Crowson C.S.
        • Nicola P.J.
        • Ballman K.V.
        • Roger V.L.
        • Jacobsen S.J.
        • Gabriel S.E.
        Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
        Arth Rheum. 2005; 52: 402-411
        • Roman M.J.
        • Moeller E.
        • Davis A.
        • Paget S.A.
        • Crow M.K.
        • Lockshin M.D.
        • Sammaritano L.
        • Devereux R.B.
        • Schwartz J.E.
        • Levine D.M.
        • Salmon J.E.
        Preclinical carotid atherosclerosis in patients with rheumatoid arthritis.
        Ann Intern Med. 2006; 144: 249-256
        • Wolfe F.
        • Michaud K.M.S.
        Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti–tumor necrosis factor therapy.
        Am J Med. 2004; 116: 305-311
        • Kremers H.M.
        • Crowson C.S.
        • Therneau T.M.
        • Roger V.L.
        • Gabriel S.E.
        High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study.
        Arthritis Rheum. 2008; 58: 2268-2274
        • Gabriel S.E.
        • Crowson C.S.
        • O'Fallon W.M.
        The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985.
        Arthritis Rheum. 1999; 42: 415-420
        • Solomon D.H.
        • Karlson E.W.
        • Rimm E.B.
        • Cannuscio C.C.
        • Mandl L.A.
        • Manson J.E.
        • Stampfer M.J.
        • Curhan G.C.
        Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.
        Circulation. 2003; 107: 1303-1307
        • Padyukov L.
        • Silva C.
        • Stolt P.
        • Alfredsson L.
        • Klareskog L.
        • Epidemiological Investigation of Rheumatoid Arthritis Study Group
        A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis.
        Arthritis Rheum. 2004; 50: 3085-3092
        • Escalante A.
        • Haas R.W.
        • del Rincon I.
        Paradoxical effect of body mass index on survival in rheumatoid arthritis.
        Arch Intern Med. 2005; 165: 1624-1629
        • Wasco M.C.M.
        Rheumatoid arthritis and cardiovascular disease.
        Curr Rheumatol Rep. 2008; 10: 390-397
        • Wasko M.C.M.
        • Hubert H.B.
        • Bharathi Lingala V.B.
        • Elliott J.R.
        • Luggen M.E.
        • Fries J.F.
        • Ward M.M.
        Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis.
        JAMA. 2007; 298: 187-193
        • Wallace D.J.
        • Metzger A.L.
        • Stecher V.J.
        • Turnbull B.A.
        • Kern P.A.
        Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids.
        Am J Med. 1990; 89: 322-326
        • Liang K.P.
        • Kremers H.M.
        • Crowson C.S.
        • Snyder M.R.
        • Therneau T.M.
        • Roger V.L.
        • Gabriel S.E.
        Autoantibodies and the risk of cardiovascular events.
        J Rheumatol. 2009; 36: 2462-2469
        • Cecelia P.
        • Chung C.P.
        • Oeser A.
        • Solus J.F.
        • Avalos I.
        • Gebretsadik
        • Shintani A.
        • Raggi P.
        • Sokka T.
        • Pincus T.
        • Stein C.M.
        Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis.
        Atherosclerosis. 2008; 196: 756-763
        • Charles-Schoeman C.
        • Khanna D.
        • McMahon M.
        • Reddy S.T.
        • Fogelman A.M.
        • Paulus H.E.
        • Park G.S.
        • Gong T.
        • Ansell B.J.
        Effects of high-dose atorvastatin on anti-inflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.
        J Rheumatol. 2007; 34: 1459-1464
        • Peter M.J.L.
        • van Halm V.P.
        • Voskuyl A.E.
        • Smulders Y.M.
        • Boers M.
        • Lems W.F.
        • Visser M.
        • Stehouwer C.D.A.
        • Dekker J.M.
        • Nijpels G.
        • Heine R.
        • Dijkmans B.A.C.
        • Nurmohamed M.T.
        Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease: a prospective study.
        Arth Rheum. 2009; 61: 1571-1579
        • Choi H.K.
        • Hernán M.A.
        • Seeger J.D.
        • Robins J.M.
        • Wolfe F.
        Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.
        Lancet. 2002; 359: 1173-1177
        • Landewe R.B.M.
        • van den Borne B.E.
        • Breedveld F.C.
        • Dijkmans B.A.C.
        Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity.
        Lancet. 2000; 355: 1616-1617
        • Nicola P.J.
        • Maradit-Kremers H.
        • Roger V.L.
        • Jacobsen S.J.
        • Crowson C.S.
        • Ballman K.V.
        • Gabriel S.E.
        The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
        Arthritis Rheum. 2005; 52: 412-420
        • Crowson C.S.
        • Nicola P.J.
        • Kremers H.M.
        • W. O'Fallon W.M.
        • Therneau T.M.
        • Jacobsen S.J.
        • Roger V.L.
        • Ballman K.V.
        • Gabriel S.E.
        How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?.
        Arthritis Rheum. 2005; 52: 3039-3044
        • Mann D.L.
        Inflammatory mediators and models in heart failure; a combinatorial approach.
        Circ Res. 2002; 91: 988-998
        • Coletta A.P.
        • Clark A.L.
        • Banarjee P.
        • Cleland J.G.F.
        Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH.
        Eur J Heart Fail. 2002; 4: 559-561
        • Listing J.
        • Strangfeld A.
        • Kekow J.
        • Schneider M.
        • Kapelle A.
        Does tumor necrosis factor inhibition promote or prevent heart failure in patients with rheumatoid arthritis?.
        Arthritis Rheum. 2008; 58: 667-677
      1. Available at: http://www.enbrel.com/prescribing-information.jsp. Accessed July 27, 2009.

        • White W.B.
        Defining the problem of treating the patient with hypertension and arthritis pain.
        Am J Med. 2009; 122: S3-S9
        • McCarey D.W.
        • McInnes I.B.
        • Madhok R.
        • Hampson R.
        • Scherbakov O.
        • Ford I.
        • Capell H.A.
        • Sattar N.
        Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.
        Lancet. 2004; 363: 2015-2021
        • Mooney D.P.
        • O'Reilly M.
        • Gamelli R.L.
        Tumor necrosis factor and wound healing.
        Ann Surg. 1990; 211: 124-130

      Linked Article